ALZAlzinova AB
0.8190SEK0.00%Mkt Cap: 15.87M $P/E: —3d ago
Alzinova AB (publ), a clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer's disease in Sweden. The company's lead product candidate is the ALZ-101, a therapeutic vaccine for the treatment o…